Monitoring in critical care

85
Co-ordinator:- Dr. Navab Singh(M.D) Co-ordinator:- Dr. Navab Singh(M.D) Speaker:- Dr. Uday Pratap Speaker:- Dr. Uday Pratap

Transcript of Monitoring in critical care

Page 1: Monitoring in critical care

Co-ordinator:- Dr. Navab Singh(M.D)Co-ordinator:- Dr. Navab Singh(M.D)Speaker:- Dr. Uday PratapSpeaker:- Dr. Uday Pratap

Page 2: Monitoring in critical care

• Sickest patients (multiple diagnosis, multi organ failure, immunocompromised, septic and trauma)

• Move less

• Malnourished

• More obtunded (Glasgow coma scale)

• May be associated Diabetics and Heart failure

Page 3: Monitoring in critical care

“Repeated or continuous observations or measurements

of the patient, physiological function, and the function

of life support equipment, for the purpose of guiding

management decisions, including when to make

therapeutic interventions, and assessment of those

interventions”

A patient monitor may not only alert caregivers to

potentially life-threatening events; many provide

physiologic input data used to control directly

connected life-support devices.

Page 4: Monitoring in critical care

There are at least four categories of patients who need physiologic monitoring:

1. Patients with unstable physiologic regulatory systems; for example, a patient

whose respiratory system is suppressed by a drug overdose or anesthesia.

2. Patients with a suspected life-threatening condition; for example, a patient who has

findings indicating an acute myocardial infarction (heart attack).

3. Patients at high risk of developing a life-threatening condition; for example,

patients immediately post open-heart surgery, or a premature infant whose heart and

lungs are not fully developed.

4. Patients in a critical physiological state; for example, patients with multiple trauma

or septic shock.

Page 5: Monitoring in critical care

Common to all patients

◦ Pulse oxymetry◦ BP monitoring◦ Non invasive

Invasive CVP

◦ ECG◦ Temprature◦ Urine output◦ ABG

Page 6: Monitoring in critical care

ICP monitoring GCS scoring Spinal cord fn monitoring BIS monitor EEG

Page 7: Monitoring in critical care

BIS TechnologyBIS Technology

BIS Monitor

BIS Modules

BIS Sensor

Page 8: Monitoring in critical care

Sensor ApplicationSensor Application

Apply sensor on forehead at angle

Circle #1: Centered, 2 inches above nose

Circle #4: Directly above eyebrow

Circle #3: On temple, between corner of eye and hairline

Press around the edges of each circle to assure adhesion

Press each circle for 5 seconds

Page 9: Monitoring in critical care

Level of consciousness Pupils

◦ Size◦ Reactivity◦ Equality

Cerebral perfusion pressure (>70mmHg)◦ CPP = MAP- ICP

Intracranial pressure (<10mmHg)

Page 10: Monitoring in critical care
Page 11: Monitoring in critical care

Mixed venous saturation◦ Measured with PA catheter◦ Normal is 65-75%◦ Low SvO2 may indicate inadequate tissue O2 delivery (even if arterial O2 is OK)

Lactates◦ Increased lactate concentration and metabolic acidosis suggests

anaerobic metabolism and inadequate tissue oxygenation. lactate also increases with liver failure and sepsis,

ABG monitoring◦ Monitors acid-base balance, PaO2, and PaCO2

Gastric tonometry Used to detect shock-induced splanchnic ischemia by measure gastric luminal PCO2

and deriving the mucosal pH

Page 12: Monitoring in critical care

PA catheter TEE JVP CO monitor

Page 13: Monitoring in critical care
Page 14: Monitoring in critical care

NM- monitor: standard method of monitoring drug induced NM block is to apply a series of four low frequency(2Hz) electrical pulse to ulnar nerve at forearm, and observe for adduction of thumb.

Total absence of thumb adduction is evidence of excessive block. Desired goal is 1or 2 preceptible twitches, and drug infusion is

adjusted to achieve end point.

Capnography◦ End-tidal CO2 concentration is close to artrial PaCO2 levels◦ Indicates the adequacy of alveolar ventilation

Pain scoring Spirometry Plasma level of various drugs X-ray chest

Page 15: Monitoring in critical care

Global measures◦ Reflect the adequacy of total tissue perfusion but could be

normal with local perfusion abnormalities◦ SvO2 <55% indicates global tissue hypoxia.

Organ-specific Measures◦ Urine flow

A sensitive indicator of renal perfusion provided the kidneys aren’t damaged

Normal is 1ml/kg

◦ Core-peripheral temperature The gradient between peripheral (skin) temp and core

(rectal) is often used as an index of peripheral perfusion The less perfusion, the colder the periphery

Page 16: Monitoring in critical care

04/12/23Dr.T.V.Rao MD 16

Page 17: Monitoring in critical care

1- Acute respiratory failure due to:

Mechanical failure, includes neuromuscular diseases as Myasthenia Gravis, Guillain-Barré Syndrome, and Poliomyelitis (failure of the normal respiratory neuromuscular system)

Musculoskeletal abnormalities, such as chest wall trauma (flail chest)

Infectious diseases of the lung such as pneumonia, tuberculosis.

2- Abnormalities of pulmonary gas exchange as in:

Obstructive lung disease in the form of asthma, chronic bronchitis or emphysema.

Conditions such as pulmonary edema, atelectasis, pulmonary fibrosis.

Patients who has received general anesthesia as well as post cardiac arrest patients often require ventilatory support until they have recovered from the effects of the anesthesia or the insult of an arrest.

Page 18: Monitoring in critical care

ParametersParameters Ventilation Ventilation indicatedindicated

Normal Normal rangerange

A- Pulmonary functionA- Pulmonary function

studiesstudies::

• Respiratory rate Respiratory rate

(breaths/min).(breaths/min).

• Tidal volume (ml/kgTidal volume (ml/kg

body wt)body wt)

• Vital capacity (ml/kg Vital capacity (ml/kg

body wt)body wt)

• Maximum InspiratoryMaximum Inspiratory

Force (cm HOForce (cm HO2) )

> >3535

< <55

< <1515

-<-<2525

10-2010-20

88 - -1010

65-7565-75

75-10075-100

Page 19: Monitoring in critical care

ParametersParameters Ventilation Ventilation indicatedindicated

Normal Normal rangerange

B- Arterial bloodB- Arterial blood

GasesGases

• PHPH

• PaOPaO2 (mmHg) (mmHg)

• PaCOPaCO2 (mmHg) (mmHg)

< <7.257.25

< <6060

> >5050

7.35-7.457.35-7.45

75-10075-100

35-4535-45

Page 20: Monitoring in critical care

Negative-pressure ventilators

Early negative-pressure ventilators were known as “iron lungs.”

The patient’s body was encased in an iron cylinder and negative pressure was generated .

Intermittent short-term negative-pressure ventilation is sometimes used in patients with chronic diseases.

The iron lung are still occasionally used today.

Positive-pressure ventilators are deliver gas to the patient under positive-pressure, during the inspiratory phase.

Page 21: Monitoring in critical care
Page 22: Monitoring in critical care

A- Volume Modes1- Assist-control (A/C)

2- Synchronized intermittent mandatory ventilation (SIMV)

B- Pressure Modes

1. Pressure-controlled ventilation (PCV) 2- Pressure-support ventilation (PSV)

3- Continuous positive airway pressure (CPAP)

4- Positive end expiratory pressure (PEEP)

5- Noninvasive bilevel positive airway pressure ventilation (BiPAP)

Page 23: Monitoring in critical care

ventilator provides the patient with a pre-set tidal volume at a pre-set rate .

Patient may initiate a breath on his own, but the ventilator assists by delivering a specified tidal volume to the patient. pt can initiate breaths that are delivered at the preset tidal volume.

Pt. can breathe at a higher rate than the preset number of breaths/minute.

The total respiratory rate is determined by the number of spontaneous inspiration initiated by the patient plus the number of breaths set on the ventilator.

In A/C mode, a mandatory (or “control”) rate is selected.

If the patient wishes to breathe faster, pt. can trigger the ventilator and receive a full-volume breath.

Page 24: Monitoring in critical care

Often used as initial mode of ventilation

When the patient is too weak to perform the work of breathing (e.g., when emerging from anesthesia).

Disadvantages:

Hyperventilation,

Page 25: Monitoring in critical care

The ventilator provides the patient with a pre-set number of breaths/minute at a specified tidal volume and FiO2.

In between the ventilator-delivered breaths, the patient is able to breathe spontaneously at his own tidal volume and rate with no assistance from the ventilator.

However, unlike the A/C mode, any breaths taken above the set rate are spontaneous breaths taken through the ventilator circuit.

The tidal volume of these breaths can vary drastically from the tidal volume set on the ventilator, because the tidal volume is determined by the patient’s spontaneous effort.

Page 26: Monitoring in critical care

Adding pressure support during spontaneous breaths can minimize the risk of increased work of breathing.

Ventilators breaths are synchronized with the patient spontaneous breathe( no fighting).

Used to wean the patient from the mechanical ventilator.

Weaning is accomplished by gradually lowering the set rate and allowing the patient to assume more work

Page 27: Monitoring in critical care

Ingento EP & Drazen J: Mechanical Ventilators, in Hall JB, Scmidt GA, & Wood LDH(eds.): Principles of Critical Care

Page 28: Monitoring in critical care

Ventilation is completely provided by the mechanical ventilator with a preset tidal volume, respiratory rate and oxygen concentration

Ventilator totally controls the patient’s ventilation i.e. the ventilator initiates and controls both the volume delivered and the frequency of breath.

Client does not breathe spontaneously.

Client can not initiate breathe

Page 29: Monitoring in critical care
Page 30: Monitoring in critical care

The PCV mode is used

◦ If compliance is decreased and the risk of barotrauma is high.

◦ It is used when the patient has persistent oxygenation problems despite a high FiO2 and high levels of PEEP.

The inspiratory pressure level, respiratory rate, and inspiratory–expiratory (I:E) ratio must be selected.

Page 31: Monitoring in critical care

Sedation and the use of neuromuscular blocking agents are frequently indicated, because any patient–ventilator asynchrony usually results in profound drops in the SaO2.

This is especially true when inverse ratios are used. The “unnatural” feeling of this mode often requires muscle relaxants to ensure patient–ventilator synchrony.

Inverse ratio ventilation (IRV) mode reverses this ratio so that inspiratory time is equal to, or longer than, expiratory time (1:1 to 4:1).

Inverse I:E ratios are used in conjunction with pressure control to improve oxygenation by expanding stiff alveoli by using longer distending times, thereby providing more opportunity for gas exchange and preventing alveolar collapse.

Page 32: Monitoring in critical care

The patient breathes spontaneously while the ventilator applies a pre-determined amount of positive pressure to the airways upon inspiration.

Pressure support ventilation augments patient’s spontaneous breaths with positive pressure boost during inspiration i.e. assisting each spontaneous inspiration.

Helps to overcome airway resistance and reducing the work of breathing.

Indicated for patients with small spontaneous tidal volume and difficult to wean patients.

Patient must initiate all pressure support breaths.

Pressure support ventilation may be combined with other modes such as SIMV or used alone for a spontaneously breathing patient.

Page 33: Monitoring in critical care

The patient’s effort determines the rate, inspiratory flow, and tidal volume.

In PSV mode, the inspired tidal volume and respiratory rate must be monitored closely to detect changes in lung compliance.

It is a mode used primarily for weaning from mechanical ventilation.

Page 34: Monitoring in critical care

Constant positive airway pressure during spontaneous breathing

CPAP allows the nurse to observe the ability of the patient to breathe spontaneously while still on the ventilator.

CPAP can be used for intubated and nonintubated patients.

It may be used as a weaning mode and for nocturnal ventilation (nasal or mask CPAP)

Page 35: Monitoring in critical care

Positive pressure applied at the end of expiration during mandatory \ ventilator breath

Page 36: Monitoring in critical care

Prevent atelactasis or collapse of alveoli

Treat atelactasis or collapse of alveoli Improve gas exchange & oxygenation Treat hypoxemia refractory to oxygen therapy.(prevent

oxygen toxicity

Treat pulmonary edema ( pressure help expulsion of fluids from alveoli

Page 37: Monitoring in critical care

BiPAP is a noninvasive form of mechanical ventilation provided by means of a nasal mask or nasal prongs, or a full-face mask.

The system allows the clinician to select two levels of positive-pressure support:

An inspiratory pressure support level (referred to as IPAP)

An expiratory pressure called EPAP (PEEP/CPAP level).

Page 38: Monitoring in critical care

1- T-piece trial,

2- Continuous Positive Airway Pressure (CPAP) weaning,

3- Synchronized Intermittent Mandatory Ventilation (SIMV) weaning,

4- Pressure Support Ventilation (PSV) weaning.

Page 39: Monitoring in critical care

Awake and alert

Hemodynamically stable, adequately resuscitated, and not requiring vasoactive support

Arterial blood gases (ABGs) normalized or at patient’s baseline - PaCO2 acceptable - PH of 7.35 – 7.45 - PaO2 > 60 mm Hg , - SaO2 >92% - FIO2 ≤40% Positive end-expiratory pressure (PEEP) ≤5 cm H2O Vt 5 ml / kg VC > 10- 15 ml / kg PEP (positive expiratory pressure) > - 20 cm H2O ( indicates

patient’s ability to take a deep breath & cough),

Page 40: Monitoring in critical care

◦ Catecholamines◦ Glucocorticoids and◦ Mineralocorticoids◦ Insulin◦ Glucagon◦ Thyroid hormone◦ Growth hormone◦ Parathyroid hormone

Page 41: Monitoring in critical care

Movement

Sequential Compression Devices

Pharmacologic treatment◦ UFH decrease incidence of DVT by 20%.(initial bolus dose of 80

IU/kg and follow with continuous infusion of 18IU/kg/hr, check PTT 6hr after start of infusion)

◦ LMWH decrease incidence of DVT by 30% over UFH.

Page 42: Monitoring in critical care

Type of fluid that is best designed to correct a specific problem with fluid balance is:

Crystalloid fluids are designed to fill extracellular space are would be use in pt. With dehydration, (loss of interstitial &intravascular fluid).

Colloid fluid are designed to expand the plasma volume and are appropriate for pt. With hypovolemia due to blood loss.

Albumin containing colloid fluid are appropriate for pt. With hypovolemia associated with hypoalbuminemia.

Page 43: Monitoring in critical care

Regular oral and teeth cleaning should be done at lest 12 hrly. Prevent aspiration

1. Positioning—lateral position with head turned to the side or side-lying. Position back of head on a pillow so that the face tips forward and fluid/ secretions will flow out of the mouth, not back into the throat.

Place a bulb syringe or suction machine with suction equipment nearby.

Care of eyes: Clean from inner to outer conthus with wet (normal saline), warm

cotton ball or compress. Use artificial tear solution or normal saline every four hour, if blink

reflex is absent. Care for eye glass, contact lens.

Page 44: Monitoring in critical care

Repositioning the ETT move it to a different location on the patient’s mouth avoiding areas of breakdown and ulceration.

Skin preparation is required when using tapes or devices with adhesives. This may include:

-Shaving (consent may be required before shaving), cleaning and drying. - Preparation with skin prep solutions such antiseptic.

If an ETT requires advancing or withdrawing, the patient’s oral airway should be suctioned and then the cuff deflated prior to moving the ETT.

ETT cuff pressure is monitored to minimize the risk of tracheal necrosis and to reduce aspiration of oral secretions into the airway.

Cuff pressure should be monitored at least every four hours.

Page 45: Monitoring in critical care

ETT cuff pressure should be maintained at a minimum of 25 cmH2O to reduce the risk of secretions leaking into the trachea and bronchi.

Maximum cuff pressure is 30 cmH20 to avoid the risk of tracheal necrosis.

The measuring device connects to the one way valve of the ETT pilot balloon and the pressure is read at end of inspiration.

ETT suctioning should be performed at least 4-6hrly to ensure airway patency.

Perform hand hygiene prior to using the in-line suction.

Always wear gloves and eye protection.

Page 46: Monitoring in critical care

Suctioning is the mechanical aspiration of pulmonary secretions from a patient with an artificial airway in place.

Indications◦ Inability to cough effectively◦ Sputum plugging

To assess tube patency

Contraindication Frank haemoptysis Severe brochospasm Undrained pneumothorax Compromised cardiovascular system

Page 47: Monitoring in critical care

The suction catheter used must be less than half the diameter of endotracheal tube.

The vacuum pressure should be as low as possible. (60-150mmHg)

Suction should never be routine, only when there is an indication

Hazards of suctioning Mucosal trauma Cardiac arrhythmias Hypoxia Raised intracranial pressure

Page 48: Monitoring in critical care

To be given every four hours

Skin around tracheostomy tube cleaned with betadine

Inner cannula of metal tracheostomy -cleaned under running water

-immersed in hydrogen peroxide for 10mts

- washed with water and gauze wick -boiled for 10 mints and replaced once It is cool

Page 49: Monitoring in critical care

Nosocomial infections◦ occur in approximately 10% of ICU patients at a rate of

21 to 25 infections per 1000 ICU patient-days.

◦ The most common nosocomial infections in medical ICUs are urinary tract infections (31%), followed by pneumonia (27%) and primary bloodstream infections (19%).

Page 50: Monitoring in critical care

VAP is defined as pneumonia developing in mechanically ventilated patients after more than 48 hours of intubation, with no clinical evidence suggesting the presence or probable development of pneumonia at the time of initial intubation.

VAP is a leading cause of morbidity and mortality in mechanically ventilated, critically ill patients.

Page 51: Monitoring in critical care

The incidence of VAP is estimated to be 10% to 25%, and the estimated mortality rate from VAP is 5% to 27%. VAP also increases hospital length of stay and cost.

The diagnosis of VAP is challenging. presumptive diagnosis of pneumonia is made when fever, leukocytosis, purulent secretions, and a new infiltrate on chest radiography develop and when bacteria are isolated by nonquantitative analysis of endotracheal aspirates.

These nonspecific diagnostic criteria may lead to unnecessary antibiotic use, increased hospital cost, emergence of resistant microorganisms, and a potential delay in diagnosis of the true cause of the fever.

Page 52: Monitoring in critical care

Host Factors Factors that facilitate reflux& aspiration into the lower RT

• Elderly• Severe Illness• Underlying Lung Disease - Mechanical ventilation• Depressed Mental Status - Tracheostomy• Immunocompromising - Use of a Nasogastric

TubeConditions or Treatments - Supine Position

• Viral Respiratory Tract Factors that impede normal Infection Pulmonary Toilet

Colonisation - Abdominal or thoracic surgery• Intensive Care Setting - Immobilisation• Use of Antimicrobial Agents• Contaminated hands• Contaminated Equipment

04/12/23Dr.T.V.Rao MD 52

Page 53: Monitoring in critical care

Early onset VAP is caused by Streptococcus pneumonia, H influenza, Moraxella catarrhalis and methicillin-sensitive Staphylococcus aureus (MSSA).

Late onset VAP is caused commonly by Pseudomonas aeruginosa, Acinetobacter, Enterobacter species and methicillin resistant staphylococcus aureus (MRSA).

VAP is frequently polymicrobial and gram negative bacilli are the predominant organism’s isolated.

Page 54: Monitoring in critical care

Prevention of Ventilator-Associated Pneumonia

Gastric pH The use of sucralfate, an agent that does not increase gastric pH, may be

preferable to H2 receptor antagonists or proton pump inhibitors. Three studies found decreased mortality rates in patients treated with sucralfate rather than H2 receptor antagonists or proton pump inhibitors.

Positioning Positioning of the head of the bed at 30 degrees is the most cost-effective

intervention for prevention of VAP. This position results in decreased gastroesophageal reflux.

Subglottic Aspiration of Secretions Pooling of secretions above the endotracheal tube cuff may increase the

volume of bacteria that enter the airways. Removal of these secretions by continuous aspiration in the subglottic region requires the use of a specialized endotracheal tube with a second lumen that permits a suction catheter to exit proximal to the endotracheal tube cuff.

Page 55: Monitoring in critical care

 Aminoglycosides and quinolones are bactericidal in a concentration dependent fashion.

In addition these agents have a prolonged postantibiotic effect (PAE), allowing them to suppress bacterial growth even after their concentrations are below target level.

vancomycin and the beta-lactams (penicillins, cephalosporins, aztreonam) are also bactericidal but act in a time-dependent rather than in a concentration-dependent fashion, do not possess significant postantibiotic effect against gram negative bacilli,

Generally speaking, empirical therapy should be commenced once NP is suspected and altered as microbiologic data become available

Page 56: Monitoring in critical care

Catheter-Related Bloodstream Infections

It is estimated that more than 5 million CVCs are inserted every year in the United States.

Unfortunately, more than 15% of patients have complications from these lines. Infectious complications are reported to occur in 5% to 26% of patients with

CVCs.

The mortality rate attributable to CRBSIs ranges from 12% to 25%,

Prevention of Central Venous Catheter Infections Antibiotic-Impregnated Central Venous Catheters

Examine the efficacy of antimicrobial-impregnated catheters in an effort to decrease the incidence.

CVCs coated with the antimicrobials chlorhexidine and silver sulfadiazine or impregnated with the antibiotics minocycline and rifampin are commercially available.

Chlorhexidine/sulfadiazine-coated catheters lowered the rate of bloodstream infection from 7.6 to 1.6 infections per 1000 catheter-days (P = .03).

Page 57: Monitoring in critical care

The use of antimicrobial-impregnated catheters should be considered in all critically ill patients who require long-term (at least 3 days) indwelling central venous access.

Immunocompetent patients who will be catheterized for less than 3 or 4 days may not need these catheters because infection is rare during this period.

Sterile Technique Optimal sterile technique is the most cost-effective means of

reducing the incidence of central line colonization and CRBSI. Use of maximal sterile barrier precautions such as mask, cap,

sterile gown, sterile gloves, and a large sterile drape. Use of chlorhexidine solution for skin decontamination reduces the

risk of catheter colonization and is therefore preferred over the use of povidone-iodine solution.

Ultrasound Guidance With the development of portable, inexpensive ultrasound

machines, for reducing the complications associated with central venous cannulation .

Page 58: Monitoring in critical care

Ultrasound guidance has been shown to reduce the number of complications, unsuccessful attempts, and time required for insertion of an internal jugular vein catheter,

Clinical trials assessing whether use of ultrasound can decrease the incidence of central venous line infections remain to be completed, but this technology can decrease the number of attempts required to locate the internal jugular vein and should be used routinely when available.

Duration The need for a CVC should be reassessed daily, and unnecessary catheters

should be removed because the probability of catheter-related infections increases with time.

The risk of infection with catheterization stays relatively low until about the fifth to seventh days and then increases.

Page 59: Monitoring in critical care

Establishment of pain as 5th vital sign - frequent evaluations

In cognitive impairment /delirium markers - behavioural (facial-FACS)

- physiological-BP,HR,RR

Creative assessments - teaching hand movements / blinking

Subjective quantification numeric/graphic scales (W-B faces)

Page 60: Monitoring in critical care
Page 61: Monitoring in critical care

Treatment of perceived & prevention of anticipated pain

Opiates – principal agents in ICU - potent / lack of ceiling effects - mild anxiolytic & sedative - relieves air hunger & suppress cough in resp failure

- improved patient – ventilator synchrony - effective antagonist - naloxone

Lack amnesic effects /additional sedatives required

Page 62: Monitoring in critical care

Morphine & Hydromorphine accumulation of metabolites

Pethidine - only for shivering/ drug induced rigors

Codeine/oxycodone – oral - not effective

Methadone for c/c pain/ complex pain syndromes

Fentanyl / sufentanil/ remifentanil/ alfentanil popular

Flexibility of choice essential

Page 63: Monitoring in critical care

In the agitated, ventilated & for procedure discomfort

To avoid self extubation & removal of catheters

NM blockade mandates analgesia & sedation

Control of pain before sedation

All have side effects – dose dependent Analgesics are not sedatives/ Sedatives are not analgesics

Page 64: Monitoring in critical care

Benzodiazepines most popular for sedation

Short term sedation – midazolam>3h (amnesic/ hypotension) - propofol – infusion syndrome/ pancreatitis

Long term – lorazepam>20h /diazepam<96h (not for infusion)

Delirium – haloperidol - neurolept syndrome/torsade pointes

Antagonist- flumazenil 0.2mg-1mg (withdrawal seizures)

Page 65: Monitoring in critical care

Dexmedetomidine- 2 agonist/ GABA sparing effects

Short term analgesia, sedation, anxiolysis

No cardio-respiratory depression/ easily arousable

Continuous infusion in ventilated /prior,during &post- extbn

No amnesia/ crosses placenta/

Antagonised by atipamezole – combinations useful in ICU

Page 66: Monitoring in critical care

Assess levels to vary according to course of ICU stay

Observational scales - 4 levels – min, mod, deep, GA

Ramsay sedation scale 1-6 (vocal, glabellar tap)--aim for 3-4

Direct information- ideal to assess analgesia & sedation

BIS – for deep sedated & paralysed

Page 67: Monitoring in critical care

Pancuronium

Rocuronium Cisatracurium

Dose (mg/kg) 0.1 0.6-1 0.1-2

Duration (min)

60-100 30-40 35-50

Infusion (micro grm/kg/min)

1-2 10-12 2.5-3

Effect on HR Tachycardia Mild increase at high dose

None

Effect on renal failure

Prolong effect of drug n metabolites

minimal none

Effect on hepatic failure

Mild prolonged

prolonged none

Page 68: Monitoring in critical care

Cleaning more Important than Disinfection and Sterilization

Cleaning Removes

contaminants, Dust, organic

matter,Disinfection Reduces number of

microbes

Page 69: Monitoring in critical care

Sterilization is absolute, removes microbes and spores too.

To achieve Sterilization is Expensive, not sustainable, many times not needed.

An effective Disinfection reduces the infections drastically.

Page 70: Monitoring in critical care

To Sterilization of ICU formaldehyde gas (bactericidal & sporicidal,viricidal) is widely employed as it is cheaper for sterilization of huge areas like operation theatres and ICU.

Formaldehyde kills the microbes by alkylating the amino acids and sulfydral group of proteins and purine bases.

In spite of the gas being hazardous continues to be used in several developing countreis

Page 71: Monitoring in critical care

Single closed cubicle Cases – open tb , anthrax, MARSA etc…Uv light for disinfection

Page 72: Monitoring in critical care

A Chemical compound VIRKON gaining importance as non Aldehyde compound.

Virkon proved to be safe Virucidal Bactericidal, Fungicidal Mycobactericidal used as : As a Chemical disinfectant. Disinfects Medical devices. Disinfects Laboratory equipment. Decontaminate spillages with Blood and body fluids. Finding usefulness in replacing autoclaving and saving time.

Page 73: Monitoring in critical care

Sterile water for nebulizer & humidifier

Pneumatic circuit to be changed when visibly soiled

Use heat & moisture exchange filter

Condensate in tubing to be drained only to the water traps

Humidifier domes (auto claved or sterilized by 2% glutaraldehyde)

Page 74: Monitoring in critical care

Washed under running water

Immersed in 2% glutaraldehyde for 8 to 10hrs

Page 75: Monitoring in critical care

Negative Air pressure vented to the operation theatre.

Environmental cleaning should be twice daily

Page 76: Monitoring in critical care

Use disposable suction catheter

SUCTION JAR & TUBING CHANGED EVERY 24 hrs

FILLED WITH 7% LYSOL FOR 1Hr

CLEANED WITH SOAP UNDER RUING WATER

Page 77: Monitoring in critical care

Critically Ill (Frequent Position changes, )

Stable (Progressive tilting & Ambulation)

Page 78: Monitoring in critical care

ICU rehabilitation has been shown to accelerate recovery.

Early mobilization for unconscious patients starts right from turning the patient every two hours.

Graded exercises can be started as soon as the patient regains consciousness.

Activity is required to maintain sensory input, comfort, joint mobility and healing ability .

Activity minimizes the weakness caused by loss of up to half the patients muscle mass.

Graded ambulation can be started depending on patients condition

Page 79: Monitoring in critical care

A treatment intervention employed for improving

pulmonary hygiene including positioning, chest percussion,

vibration and manual hyperinflation to assist in mobilizing

secretions in the lungs from the peripheral airways into the

more central airways so that they can be expectorated or

suctioned.

Prevent accumulation of secretions

Improve mobilization and drainage of secretions

Promote relaxation to improve breathing patterns

Page 80: Monitoring in critical care

Prophylactic - Pre-operative high risk surgical patient- Post-operative patient who is unable to

mobilize secretions- Neurological patient who is unable to cough

effectively - Patient receiving mechanical ventilation who has a

tendency to retain secretions- Patients with pulmonary disease,

who needs to improve bronchial hygiene

Page 81: Monitoring in critical care

Therapeutic

- Atelectasis due to secretions

- Retained secretions

- Abnormal breathing pattern due to primary or

secondary pulmonary dysfunction

- COPD and resultant decreased exercise

tolerance

- Musculoskeletal deformity that makes breathing

pattern and cough ineffective

Page 82: Monitoring in critical care

Thank you

Page 83: Monitoring in critical care

Decreased minute ventilation◦ Respiratory rate◦ Tidal volume

Treatment:◦ Increase respiratory rate: assure I-time not too short as

rate increased◦ Increase tidal volume◦ Allow permissive hypercarbia

Page 84: Monitoring in critical care
Page 85: Monitoring in critical care